We are live on
!
Find out more
GCM
Geneva Capital Management Portfolio holdings
AUM
$4.36B
1-Year Est. Return
17.81%
This Fund
S&P 500
This Quarter
Est. Return
+9.33%
1 Year Est. Return
+17.81%
3 Year Est. Return
+59.44%
5 Year Est. Return
+75.65%
10 Year Est. Return
–
AUM
$4.45B
AUM Growth
+$122M
(+2.8%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-3%
Top 10 Holdings %
Top 10 Hldgs %
26.71%
Holding
130
New
2
Increased
35
Reduced
87
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mesa Laboratories
MLAB
|
+$13.6M |
| 2 |
Blackbaud
BLKB
|
+$9.6M |
| 3 |
SPS Commerce
SPSC
|
+$8.65M |
| 4 |
iShares Russell 2000 Growth ETF
IWO
|
+$8.18M |
| 5 |
Construction Partners
ROAD
|
+$7.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinsale Capital Group
KNSL
|
+$35.9M |
| 2 |
LHCG
LHC Group LLC
LHCG
|
+$35.3M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$21.9M |
| 4 |
O'Reilly Automotive
ORLY
|
+$7.73M |
| 5 |
PETQ
PetIQ, Inc. Class A Common Stock
PETQ
|
+$5.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.48% |
| 2 | Industrials | 26.91% |
| 3 | Healthcare | 15.32% |
| 4 | Consumer Discretionary | 8.86% |
| 5 | Financials | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Fortune Brands Innovations
FBIN
$6.06B
| $5.55M | 0.12% |
97,124
-27,476
| -22% | -$1.44M |
|
102
Charles River Laboratories
CRL
$12.8B
| $4.37M | 0.1% |
20,050
+63
| +0.3% | +$13.8K |
|
103
Danaher
DHR
$144B
| $4.18M | 0.09% |
17,783
-1,921
| -10% | -$445K |
|
104
Thermo Fisher Scientific
TMO
$220B
| $4.17M | 0.09% |
7,578
-822
| -10% | -$436K |
|
105
Lowe's Companies
LOW
$125B
| $3.78M | 0.09% |
18,985
-2,046
| -10% | -$409K |
|
106
Costco
COST
$420B
| $3.74M | 0.08% |
8,185
-882
| -10% | -$431K |
|
107
TJX Companies
TJX
$178B
| $3.63M | 0.08% |
45,550
-4,909
| -10% | -$362K |
|
108
Microsoft
MSFT
$3.71T
| $3.62M | 0.08% |
15,115
-1,627
| -10% | -$390K |
|
109
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $3.48M | 0.08% |
41,617
-6,854
| -14% | -$577K |
|
110
Visa
V
$677B
| $3.09M | 0.07% |
14,852
-1,600
| -10% | -$323K |
|
111
Alphabet (Google) Class A
GOOGL
$4.33T
| $3.01M | 0.07% |
34,116
-3,689
| -10% | -$351K |
|
112
Microchip Technology
MCHP
$46B
| $2.93M | 0.07% |
41,763
-4,600
| -10% | -$317K |
|
113
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.6B
| $2.91M | 0.07% |
+14,518
| New | +$2.97M |
|
114
Edwards Lifesciences
EW
$51.7B
| $2.82M | 0.06% |
37,850
+1,289
| +4% | +$99.3K |
|
115
Adobe
ADBE
$105B
| $2.55M | 0.06% |
7,579
-822
| -10% | -$263K |
|
116
Walmart Inc
WMT
$890B
| $2.27M | 0.05% |
48,087
-5,184
| -10% | -$246K |
|
117
Freshpet
FRPT
$3.22B
| $2.03M | 0.05% |
38,562
-37,303
| -49% | -$2.22M |
|
118
Marvell Technology
MRVL
$196B
| $1.78M | 0.04% |
48,115
-7,782
| -14% | -$318K |
|
119
Salesforce
CRM
$158B
| $1.63M | 0.04% |
12,314
-1,324
| -10% | -$193K |
|
120
Ecolab
ECL
$79.9B
| $1.54M | 0.03% |
10,613
-1,149
| -10% | -$169K |
|
121
Motorola Solutions
MSI
$77.4B
| $1.47M | 0.03% |
5,714
-614
| -10% | -$153K |
|
122
S&P Global
SPGI
$120B
| $1.31M | 0.03% |
+3,900
| New | +$1.29M |
|
123
Walt Disney
DIS
$181B
| $1.19M | 0.03% |
13,724
-2,230
| -14% | -$213K |
|
124
MarketAxess Holdings
MKTX
$5.72B
| $1.14M | 0.03% |
4,071
-545
| -12% | -$140K |
|
125
Cerence
CRNC
$413M
| – | – |
-197,307
| Closed | -$3.11M |
|
Similar funds
SFM
EC
EQF
NEI
FIS
CFO
Geneva Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Geneva Capital Management held 130 positions worth $4.45B, up 2.8% from $4.33B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Geneva Capital Management withdrew a net $134M in Q4 2022, closing 6 positions and reducing 87 holdings. Its most notable exit was LHC Group LLC, an estimated $35.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Geneva Capital Management opened a new position in Vanguard Morningstar Small-Cap Growth ETF worth $2.91M.
- Geneva Capital Management's largest Q4 2022 buy was Vanguard Morningstar Small-Cap Growth ETF: 14,518 shares worth $2.91M.
- Geneva Capital Management added most to Mesa Laboratories in Q4 2022, an estimated $13.6M increase.
- Geneva Capital Management's biggest Q4 2022 reduction was Kinsale Capital Group, cutting an estimated $35.9M.
- Geneva Capital Management fully exited LHC Group LLC in Q4 2022, selling an estimated $35.3M.
- Geneva Capital Management's ten largest holdings make up 27% of its $4.45B portfolio in Q4 2022.
- Geneva Capital Management opened 2 new positions and closed 6 in Q4 2022.
- Geneva Capital Management's portfolio value rose 2.8% quarter-over-quarter to $4.45B.
Based on Geneva Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.